Skip to main content
Discovering the causes of cancer and the means of prevention
 

Qianlai Luo, Ph.D., joined the Infectious and Immunoepidemiology Branch (IIB) in 2019 as a postdoctoral fellow. She earned a Ph.D. in epidemiology with a concentration in infectious diseases from the University of North Carolina (UNC) at Chapel Hill, an M.S. in health ecology and health economics from Harvard University, Massachusetts, and her B.Engg. in chemical engineering from Tsinghua University, Beijing, China.

Prior to joining IIB, Dr. Luo was a postdoctoral researcher at the Center for Environmental and Respiratory Health at the University of Oulu, Finland, where she worked on environmental and climate health topics. While at UNC, she studied patient-provider communication patterns, as well as the use of integrative cancer therapies among cancer patients. Before beginning her Ph.D. studies at UNC, Dr. Luo worked in a comprehensive HIV/AIDS prevention and treatment program in southwest China.

Dr. Luo’s research interests include descriptive epidemiology, cancer prevention, and health disparities. She is currently studying cancer epidemiology in HIV-infected people with data from cancer registries and the HIV/AIDS Cancer Match Study, under the mentorship of working with Meredith Shiels, Ph.D., tenure-track investigator. She will expand her descriptive work to include other risk factors and cancer sites in future studies.